Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors

Journal of Surgical Oncology

Volumn 107, Issue 6, 2013, Pages 625-633

  Klozar, Jan ^a   Koslabova, Eva ^a,b   Kratochvil, Vit ^a   Salakova, Martina ^b   Tachezy, Ruth ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

failure rate; HPV; N classification; prognosis

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; VIRUS DNA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH TUMOR; OROPHARYNX TUMOR; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SMOKING; TREATMENT FAILURE; VIRUS DETECTION;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 84876412614     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23292     Document Type: Article

References (39)

1. Herrero R, Castellsague X, Pawlita M, et al.: Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772-1783.
2. Kreimer AR, Clifford GM, Boyle P, et al.: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
3. Schwartz SR, Yueh B, McDougall JK, et al.: Human papillomavirus infection and survival in oral squamous cell cancer: A population-based study. Otolaryngol Head Neck Surg 2001; 125: 1-9.
4. Smith EM, Ritchie JM, Summersgill KF, et al.: Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766-772.
5. Tachezy R, Klozar J, Salakova M, et al.: HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis 2005; 11: 181-185.
6. Ragin CC, Taioli E,: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer 2007; 121: 1813-1820.
7. Fakhry C, Westra WH, Li S, et al.: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
8. Klussmann JP, Weissenborn SJ, Wieland U, et al.: Human papillomavirus-positive tonsillar carcinomas: A different tumor entity? Med Microbiol Immunol (Berl) 2003; 192: 129-132.
9. Gillison ML,: Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 744-754.
10. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,: Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619.
11. Sturgis EM, Cinciripini PM,: Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110: 1429-1435.
12. Hammarstedt L, Lindquist D, Dahlstrand H, et al.: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006; 119: 2620-2623.
13. Mehanna H, Beech T, Nicholson T, et al.: Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2012 Article first published online: 20 JAN 2012, DOI: 10.1002/hed.22015
14. Gillison ML, D'Souza G, Westra W, et al.: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420.
15. Rotnaglova E, Tachezy R, Salakova M, et al.: HPV involvement in tonsillar cancer: Prognostic significance and clinically relevant markers. Int J Cancer 2011; 129: 101-110.
16. Tachezy R, Klozar J, Rubenstein L, et al.: Demographic and risk factors in patients with head and neck tumors. J Med Virol 2009; 81: 878-887.
17. Hafkamp HC, Manni JJ, Haesevoets A, et al.: Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008; 122: 2656-2664.
18. Lindel K, Beer KT, Laissue J, et al.: Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805-813.
19. Klozar J, Kratochvil V, Salakova M, et al.: HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 2008; 265: S75-S82.
20. D'Souza G, Agrawal Y, Halpern J, et al.: Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-1269.
21. Hemminki K, Dong C, Frisch M,: Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev 2000; 9: 433-437.
22. Lissowska J, Pilarska A, Pilarski P, et al.: Smoking, alcohol, diet, dentition and sexual practices in the epidemiology of oral cancer in Poland. Eur J Cancer Prev 2003; 12: 25-33.
23. Talamini R, Vaccarella S, Barbone F, et al.: Oral hygiene, dentition, sexual habits and risk of oral cancer. Br J Cancer 2000; 83: 1238-1242.
24. Rischin D, Young RJ, Fisher R, et al.: Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010; 28: 4142-4148.
25. Straetmans JM, Olthof N, Mooren JJ, et al.: Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 2009; 119: 1951-1957.
26. Mendelsohn AH, Lai CK, Shintaku IP, et al.: Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010; 120: 1788-1794.
27. Klussmann JP, Mooren JJ, Lehnen M, et al.: Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 2009; 15: 1779-1786.
28. Li W, Thompson CH, O'Brien CJ, et al.: Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003; 106: 553-558.
29. Lindquist D, Romanitan M, Hammarstedt L, et al.: Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 2007; 1: 350-355.
30. Shah J,: Head and neck surgery and oncology. Edinburgh: Mosby; 2003.
31. Ang KK, Harris J, Wheeler R, et al.: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
32. Licitra L, Perrone F, Bossi P, et al.: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636.
33. Rosenquist K, Wennerberg J, Annertz K, et al.: Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: Human papillomavirus and other risk factors. Acta Otolaryngol 2007; 127: 980-987.
34. Hampl M, Wentzensen N, Vinokurova S, et al.: Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile. J Cancer Res Clin Oncol 2007; 133: 235-245.
35. McGovern SL, Williams MD, Weber RS, et al.: Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: Case report and comparison with Slaughter's model of field cancerization. Head Neck 2010; 32: 1118-1124.
36. Slaughter DP, Southwick HW, Smejkal W,: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968.
37. Braakhuis BJ, Tabor MP, Kummer JA, et al.: A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 2003; 63: 1727-1730.
38. Begum S, Cao D, Gillison M, et al.: Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005; 11: 5694-5699.
39. Huang SH, Perez-Ordonez B, Liu FF, et al.: Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2012; 82: 276-283.